Evidence map›Paper›PMID 31577624›Full record

ArticleASAIO journal (American Society for Artificial Internal Organs : 1992)2020

Tidal Flow Perfusion for the Artificial Placenta: A Paradigm Shift.

Jacqueline C Kading, Mark W Langley, Gergely Lautner, Mark M P Jeakle, John M Toomasian, Taylor L Fegan, Rachel A Pfannes, Samantha C Toor, Mary A Reiber, Peter R Kordell and 4 more

Abstract read
In one paragraph

Article in ASAIO journal (American Society for Artificial Internal Organs : 1992), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Neonatal respiratory and cardiac ECMO in Europe.European journal of pediatrics · 2021
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jacqueline C KadingFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-5545-7118
Mark W LangleyFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.
Gergely LautnerLSA Chemistry, University of Michigan, Ann Arbor, Michigan.
Mark M P JeakleFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.
John M ToomasianFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.
Taylor L FeganFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.
Rachel A PfannesFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.
Samantha C ToorFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.
Mary A ReiberFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.
Peter R KordellLSA Physics, University of Michigan, Ann Arbor, Michigan.
Marie S CornellFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.
Robert H BartlettFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.
Alvaro Rojas-PenaFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-6197-8892
George B MychaliskaFrom the Department of Surgery, ECLS Laboratory, University of Michigan, Ann Arbor, Michigan.

Funding

Development of an Artificial Placenta for Support of Premature InfantsR01HD073475 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYCHALISKA, GEORGE BORIS · 2014 to 2018
$2.7M
Artificial Placenta DeviceR44HD078001 · NICHD · MC3, INC. · PI MYCHALISKA, GEORGE BORIS, OSTERHOLZER, KATHRYN R · 2013 to 2016
$1.5M
Development of an Artificial PlacentaR03HD062713 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYCHALISKA, GEORGE BORIS · 2010 to 2011
$146k
NICHD NIH HHS R01 HD073475NICHD NIH HHS R03 HD062713NICHD NIH HHS R44 HD078001
6 · The paper itself

Abstract

The modalities of vascular access for the extracorporeal artificial placenta (AP) have undergone many iterations over the past decade. We hypothesized that single lumen cannulation (SLC) of the jugular vein using tidal flow extracorporeal life (ECLS) support is a feasible alternative to venovenous (VV) umbilical-jugular cannulation and double lumen cannulation (DLC) and can maintain fetal circulation, stable hemodynamics, and adequate gas exchange for 24 hours. After in vitro evaluation of the tidal flow system, six preterm lambs at estimated gestational age 118-124 days (term 145 days) were delivered and underwent VV-ECLS. Three were supported using DLC and three with SLC utilizing tidal flow AP support. Hemodynamics, circuit flow, and gas exchange were monitored. Target fetal parameters were as follows: mean arterial pressure 40-60 mmHg, heart rate 140-240 beats per minute (bpm), SatO2% 60-80%, PaO2 25-50 mmHg, PaCO2 30-55 mmHg, oxygen delivery >5 ml O2/dl/kg/min, and circuit flow 100 ± 25 ml/kg/min. All animals survived 24 hours and maintained fetal circulation with stable hemodynamics and adequate gas exchange. Parameters of the tidal flow group were comparable with those of DLC. Single lumen jugular cannulation using tidal flow is a promising vascular access strategy for AP support. Successful miniaturization holds great potential for clinical translation to support extremely premature infants.

Indexed as

Artificial OrgansPlacentaAnimalsAnimals, NewbornExtracorporeal CirculationFemaleFetusHemodynamicsPerfusionPregnancySheepSheep, Domestic

Identifiers

PMID31577624
PMCPMC7103518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.